Carlos de Sousa, MD, MBA, Member of the Board. He is a senior biopharmaceutical executive and business leader with extensive international experience spanning biotechnology, pharmaceuticals, oncology, immunotherapy, business development, licensing, M&A, strategy and medical affairs.
Dr Andrew Dean, Board Member, completed his medical training in the UK, became a fellow of the Royal Australian College of Physicians in 1993. He established the palliative care services at Sir Charles Gairdner Hospital and St John of God Subiaco in Perth, later becoming professor of palliative medicine at Edith Cowan University Western Australia.
Associate Professor Paul Porter (MBBS, FRACP), Director, is the founder of Freeman Road Pty Ltd, an Australian company that specialises in early stage biomedical investments with an emphasis on global research and development collaborations. Freeman Road has investments in companies across Australia, South East Asia, Europe and the USA.